[Cardiovascular disorders in Parkinson's disease]
R Suárez-Moro1, B Castaño-García
1Hospital Valle del Nalón, Langreo, Asturias, España. rsuarezm@meditex.es
Revista De Neurologia
|March 6, 2010
Summary
Parkinson's disease (PD) involves cardiac sympathetic denervation from early stages. Recognizing and treating cardiovascular issues like orthostatic hypotension significantly improves patient quality of life.
Area of Science:
- Neurology
- Cardiology
- Autonomic Dysfunction
Context:
- Parkinson's disease (PD) is characterized by pre-symptomatic cardiac sympathetic denervation.
- This denervation impacts cardiac noradrenergic function and cardiovascular regulation.
- Diagnostic tools include the Valsalva maneuver and cardiac scintigraphy.
Purpose:
- To outline methods for assessing cardiac sympathetic function in PD patients.
- To detail the primary cardiovascular complications observed in Parkinson's disease.
Summary:
- Orthostatic hypotension is a major disabling autonomic dysfunction in PD, increasing fall-related morbidity.
- Neuronal loss, cardiac autonomic dysfunction, and Lewy bodies contribute to its development.
- Management involves dietary, postural adjustments, and medications like fludrocortisone, midodrine, and pyridostigmine.
- Supine hypertension is a potential complication of treatment.
Impact:
- Effective management of cardiovascular complications, particularly orthostatic hypotension, substantially enhances the quality of life for PD patients.
- Early detection and intervention are crucial for mitigating disease progression and improving patient outcomes.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...